# Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors

> **NCT00243490** · PHASE2 · WITHDRAWN · sponsor: **National Taiwan University Hospital** · enrollment: 5 (estimated)

## Conditions studied

- Malignant Intracranial Tumors
- Glioblastoma Multiforme
- Anaplastic Astrocytomas
- Anaplastic Oligodendrogliomas
- Anaplastic Ependymoma

## Interventions

- **PROCEDURE:** Photodynamic therapy using Photosan and LumaCare™ Lamp Model LC-122M

## Key facts

- **NCT ID:** NCT00243490
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2009-01
- **Target enrollment:** 5 (ESTIMATED)
- **Why stopped:** The Trial could not get permit from Department of Health, Taiwan; Furthermore, no research fund could support the expensive (photosensitizer) photosan
- **Last updated:** 2010-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00243490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00243490, "Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00243490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*